期刊文献+

TIPE3上调P-gp表达降低乳腺癌细胞对阿霉素的敏感性

TIPE3 decreases breast cancer cell sensitivity to adriamycin by upregulating P-gp protein expression
原文传递
导出
摘要 目的探讨新的促癌分子肿瘤坏死因子-α诱导蛋白8样蛋白3(TIPE3)是否影响乳腺癌细胞MCF-7对阿霉素的敏感性及其机制。方法以0、0.5、1.0、1.5μg/m L阿霉素作用于TIPE3表达质粒转染的MCF-7细胞,分别采用细胞活性检测试剂盒(CCK-8)、流式细胞术分析TIPE3对阿霉素作用的MCF-7细胞相对活性及细胞周期分布的影响;采用Annexin V/PI染色流式细胞术检测分析TIPE3对阿霉素作用的MCF-7细胞凋亡的影响;采用实时荧光定量PCR(qRT-PCR)法和蛋白印记(Western blotting)法检测核因子-kappa B(NF-κB)信号通路活化情况、多药耐药基因1(MDR 1)及多药耐药蛋白P-糖蛋白(P-gp)的表达。结果过表达TIPE3增加了阿霉素处理MCF-7细胞的相对存活率和G2/M期细胞数,降低细胞凋亡率;NF-κB信号通路活化水平增加,多药耐药基因MDR1及其表达蛋白P-gp的表达水平升高。结论 TIPE3通过活化NF-κB信号通路上调P-gp的表达进而降低MCF-7细胞对阿霉素的敏感性。 Objective To investigate the mechanisms of tumor necrosis factor-or induced protein 8 like 3 ( TIPE3 ), a recently investigated oncogenic transfer protein, on modulating breast cancer cell MCF-7 sensitivity to adriamycin. Methods TIPE3-overexpressed MCF-7 cells were treated with 0, 0.5, 1.0, 1.5 p,g/mL adriamycin. After that, the relative viability and cell cycle of MCF-7 cells were detected with CCK-8 method and flow cytometry; the apoptosis of MCF-7 cells was assessed with Annexin V/PI; expression of MDR I/P-gp and activation of NF-KB signal pathway were detected with qRT-PCR and Western blotting. Results Overexpressed TIPE3 promoted MCF-7 cell proliferation, increased the number of G2/M cells and inhibited apoptosis. Furthermore, overexpressed TIPE3 protein upregulated the activation of NF-KB signal pathway and the expression of MDR1/P-gp. Conclusion TIPE3 decreased MCF-7 cells sensitivity to adriamycin by upregulating the expression of P-gp via NF-κB pathway.
出处 《山东大学学报(医学版)》 CAS 北大核心 2017年第5期36-42,共7页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金(81171578 81100205) 山东大学基本科研业务费(2014JC010) 山东省重点研发计划(2016GSF201017)
关键词 肿瘤坏死因子-α诱导蛋白8样蛋白3 乳腺癌 P-糖蛋白 核因子-KAPPA B 阿霉素 Tumor necrosis factor-ct induced protein 8 like 3 Breast cancer P-gp Nuclear factor-kappa B Adriamycin
  • 相关文献

参考文献6

二级参考文献115

  • 1万小云,毛愉燕,横山康宏.PTEN基因转染的子宫内膜癌细胞对阿霉素诱导凋亡的敏感性[J].中华肿瘤杂志,2005,27(9):513-515. 被引量:3
  • 2Ayla S, Seckin I, Tartriverdi G, et al. Doxorubicin induced nephrotoxicity: protective effect of nicotinamide. Int J Cell Biol, 2011, 2011:390238.
  • 3Bisht S, Maitra A. Dextran-doxorubicin/chitosan nanoparticles for solid tumor therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol, 2009, 1(4):415-425.
  • 4Batrakova EV, Li S, Brynskikh AM, et al. Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers. J Control Release, 2010, 143(3):290-301.
  • 5Hanusova V, Bousova I, Skalova L. Possibilities to increase the effectiveness of doxorubicin in cancer cells killing. Drug Metab Rev, 2011, 43(4):540-557.
  • 6Feridooni T, Hotchkiss A, Remley-Carr S, et al. Cardiomyocyte specific ablation of p53 is not sufficient to block doxombicin induced cardiac fibrosis and associated cytoskeletal changes. PLoS One, 2011, 6(7):e22801.
  • 7Zhou Y, Li G, Ji Y, et al. Cytoplasmic p21 induced by p65 prevents doxorubicin-induced cell death in pancreatic carcinoma cell line. J Biomed Sci, 2012, 19:15.
  • 8Zheng T, Wang J, Song X, et al. Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways. J Cancer Res Clin Oncol, 2010, 136(10):1597-1604.
  • 9Manna SK, Gangadharan C, Edupalli D, et al. Ras puts the brake on doxorubicin-mediated cell death in p53-expressing cells. J Biol Chem, 2011,286(9):7339-7347.
  • 10Chen Y, Wan Y, Wang Y, et al. Antieancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles. Int J Nanomedicine, 2011, 6:2321-2326.

共引文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部